Qlucore Ab (Publ)

Stockholm Stock Exchange QCORE.ST

Qlucore Ab (Publ) EBIT for the year ending April 30, 2024: USD -1.72 M

Qlucore Ab (Publ) EBIT is USD -1.72 M for the year ending April 30, 2024, a -13.61% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Qlucore Ab (Publ) EBIT for the year ending April 30, 2023 was USD -1.52 M, a -30.02% change year over year.
  • Qlucore Ab (Publ) EBIT for the year ending April 30, 2022 was USD -1.17 M, a -78.09% change year over year.
  • Qlucore Ab (Publ) EBIT for the year ending April 30, 2021 was USD -654.33 K, a -898.24% change year over year.
  • Qlucore Ab (Publ) EBIT for the year ending April 30, 2020 was USD -65.55 K, a -23.49% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Stockholm Stock Exchange: QCORE.ST

Qlucore Ab (Publ)

CEO Mr. Carl-Johan Ivarsson MSc
IPO Date Nov. 5, 2021
Location Sweden
Headquarters Ideon Science Park
Employees 21
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Qlucore AB (publ) provides bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics AI software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Diagnostics, a software platform for multi-omics companion and precision diagnostics; and Qlucore Insights, a software for clinical data analysis. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

StockViz Staff

January 15, 2025

Any question? Send us an email